Department of Functional Genomics and Cancer, Institut National de la Santé et de la Recherche Médicale U964, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7104, Université de Strasbourg, BP 10142, 67404 Illkirch Cedex, France.
Proc Natl Acad Sci U S A. 2011 Dec 20;108(51):20603-8. doi: 10.1073/pnas.1102572108. Epub 2011 Dec 6.
SRC-3 is an important coactivator of nuclear receptors including the retinoic acid (RA) receptor α. Most of SRC-3 functions are facilitated by changes in the posttranslational code of the protein that involves mainly phosphorylation and ubiquitination. We recently reported that SRC-3 is degraded by the proteasome in response to RA. Here, by using an RNAi E3-ubiquitin ligase entry screen, we identified CUL-3 and RBX1 as components of the E3 ubiquitin ligase involved in the RA-induced ubiquitination and subsequent degradation of SRC-3. We also show that the RA-induced ubiquitination of SRC-3 depends on its prior phosphorylation at serine 860 that promotes binding of the CUL-3-based E3 ligase in the nucleus. Finally, phosphorylation, ubiquitination, and degradation of SRC-3 cooperate to control the dynamics of transcription. In all, this process participates to the antiproliferative effect of RA.
SRC-3 是核受体(包括视黄酸(RA)受体 α)的一个重要共激活子。SRC-3 的大多数功能都是通过蛋白质翻译后的修饰来促进的,主要涉及磷酸化和泛素化。我们最近报道,SRC-3 在受到 RA 刺激时会被蛋白酶体降解。在这里,我们通过使用 RNAi E3-泛素连接酶入口筛选,鉴定出 CUL-3 和 RBX1 是参与 RA 诱导的 SRC-3 泛素化和随后降解的 E3 泛素连接酶的组成部分。我们还表明,RA 诱导的 SRC-3 泛素化依赖于其在丝氨酸 860 处的先前磷酸化,这促进了核内基于 CUL-3 的 E3 连接酶的结合。最后,SRC-3 的磷酸化、泛素化和降解共同控制转录的动力学。总之,这个过程参与了 RA 的抗增殖作用。